Version 1
: Received: 24 April 2024 / Approved: 24 April 2024 / Online: 24 April 2024 (11:05:05 CEST)
How to cite:
Renteln, M. Microglial Replacement and COURIER or SPIT for Neuronal Gene Editing. Preprints2024, 2024041620. https://doi.org/10.20944/preprints202404.1620.v1
Renteln, M. Microglial Replacement and COURIER or SPIT for Neuronal Gene Editing. Preprints 2024, 2024041620. https://doi.org/10.20944/preprints202404.1620.v1
Renteln, M. Microglial Replacement and COURIER or SPIT for Neuronal Gene Editing. Preprints2024, 2024041620. https://doi.org/10.20944/preprints202404.1620.v1
APA Style
Renteln, M. (2024). Microglial Replacement and COURIER or SPIT for Neuronal Gene Editing. Preprints. https://doi.org/10.20944/preprints202404.1620.v1
Chicago/Turabian Style
Renteln, M. 2024 "Microglial Replacement and COURIER or SPIT for Neuronal Gene Editing" Preprints. https://doi.org/10.20944/preprints202404.1620.v1
Abstract
Adeno-associated viral (AAV) vectors can be used for gene delivery.AAV.CAP-Mac was recently developed; it can cross the blood-brain barrier and transduce cells throughout the CNS.However, some brain regions were not transduced in adult rhesus monkeys.Additionally, AAV vectors can only package 5 kb of DNA.Also, AAV vectors may be genotoxic and cytotoxic, especially at high doses.Finally, AAV vectors are very expensive to produce at sufficiently high titers for treatment.Off-the-shelf cell-based delivery systems wherein the cells can infiltrate the target tissue and be hyper-motile would be ideal.Also, mRNA-based gene editing would be a transient treatment, and thus be much safer.
Keywords
microglial replacement; adeno-associated viral (AAV) vectors; COURIER; SPIT; base editing; prime editing
Subject
Biology and Life Sciences, Biology and Biotechnology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.